Understand the impact of switching to a commercially available infant formula on gastrointestinal symptoms
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
51
Routine infant formula with probiotic
Norwich Pediatrics Group
Norwich, Connecticut, United States
Qualmedica Research
Owensboro, Kentucky, United States
Ohio Pediatric Research Association
Dayton, Ohio, United States
Coastal Pediatric Associates
Charleston, South Carolina, United States
Infant GI Symptom Burden
Study personnel will administer questionnaire
Time frame: 3 weeks
Formula Intake
Caregivers will document on diary records
Time frame: 24 hours
Fussiness
Caregivers will document on diary records
Time frame: 24 hours
Formula Satisfaction Questionnaire
Study personnel will administer questionnaire
Time frame: 3 weeks
Adverse Events
Assessed throughout study
Time frame: 24 hours and 3 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Midsouth Center for Clinical Research, LLC
Memphis, Tennessee, United States
ClinPoint Trials
Waxahachie, Texas, United States
Tanner Clinic
Layton, Utah, United States